| Serial Number | 90507936 |
| Word Mark | ORLANCE |
| Filing Date | Wednesday, February 3, 2021 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Saturday, July 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 3, 2022 |
| Goods and Services | Vaccines; vaccine preparations; medical preparations for the treatment of infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, namely, infectious diseases, respiratory diseases, mucosal diseases, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for, infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer |
| Goods and Services | Medical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, namely, automatic vaccination apparatus |
| Goods and Services | Research and development of vaccines; research and development of medicines, namely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, January 31, 2024 |
| First Use In Commerce Date | Wednesday, January 31, 2024 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 6, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, January 31, 2024 |
| First Use In Commerce Date | Wednesday, January 31, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 6, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, March 31, 2018 |
| First Use In Commerce Date | Saturday, March 31, 2018 |
| Party Name | Orlance, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104 |
| Party Name | Orlance, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104 |
| Event Date | Event Description |
| Thursday, August 26, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, February 6, 2021 | NEW APPLICATION ENTERED |
| Thursday, May 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 25, 2021 | ASSIGNED TO EXAMINER |
| Thursday, August 26, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, August 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 24, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 25, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 25, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, March 25, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, March 25, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, March 25, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, March 27, 2022 | ASSIGNED TO LIE |
| Wednesday, April 13, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 3, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 3, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 21, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 21, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, December 21, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, December 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 20, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, June 20, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, June 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 19, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, December 19, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, December 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 20, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 20, 2024 | SOU EXTENSION 4 FILED |
| Thursday, June 20, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 20, 2024 | SOU EXTENSION 4 GRANTED |
| Friday, December 13, 2024 | SOU EXTENSION 5 FILED |
| Friday, March 28, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, April 1, 2025 | SOU EXTENSION 5 GRANTED |
| Wednesday, April 2, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, June 29, 2025 | USE AMENDMENT FILED |
| Saturday, July 5, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Sunday, June 29, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, December 13, 2024 | SOU TEAS EXTENSION RECEIVED |